US 9133461
Compositions and methods for inhibiting expression of the ALAS1 gene
granted A61KA61K31/713A61K47/60
Quick answer
US patent 9133461 (Compositions and methods for inhibiting expression of the ALAS1 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 58
- CPC classes
- A61K, A61K31/713, A61K47/60, A61K48/00, A61P